Alzheimer and Parkinson Diagnoses in Progranulin Null Mutation Carriers in an Extended Founder Family
- 1 October 2007
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (10) , 1436-1446
- https://doi.org/10.1001/archneur.64.10.1436
Abstract
Research from JAMA Neurology — Alzheimer and Parkinson Diagnoses in Progranulin Null Mutation Carriers in an Extended Founder FamilyKeywords
This publication has 17 references indexed in Scilit:
- Progranulin and frontotemporal lobar degenerationActa Neuropathologica, 2007
- Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementiaHuman Mutation, 2007
- HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulinAnnals of Neurology, 2006
- Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degenerationHuman Molecular Genetics, 2006
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature, 2006
- Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Nature, 2006
- Tau is central in the genetic Alzheimer–frontotemporal dementia spectrumPublished by Elsevier ,2005
- Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesisJournal of Molecular Medicine, 2003
- Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effectsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Progression of Parkinsonism and Loss of Cognitive Function in Alzheimer DiseaseArchives of Neurology, 2000